Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Accenture
Daiichi Sankyo
Moodys
Mallinckrodt
Cipla
Argus Health
Express Scripts
Boehringer Ingelheim

Generated: May 22, 2018

DrugPatentWatch Database Preview

UROCIT-K Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Urocit-k patents expire, and what generic alternatives are available?

Urocit-k is a drug marketed by Mission Pharma and is included in one NDA.

The generic ingredient in UROCIT-K is potassium citrate. There are two hundred and thirty-five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.
Drug patent expirations by year for UROCIT-K
Medical Subject Heading (MeSH) Categories for UROCIT-K
Synonyms for UROCIT-K
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, potassium salt
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, potassium salt (1:?)
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, potassium salt (1:3)
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tripotassium salt
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tripotassium salt, monohydrate
1334-EP2380568A1
209968-03-6
6-chlorophenyl benzoate
6100-05-6
6100-05-6 (Parent)
7778-49-6
866-84-2
866-84-2 (anhydrous)
86R1NVR0HW
A841790
AC1L21JI
AC1MC2SV
AC1Q1TRD
AC1Q1TRH
ACALKA
ACMC-1B7T1
AKOS015918285
AKOS030528868
AN-20548
anhydrous potassium citrate
anhydrous tripotassium citrate
C6H5K3O7
C6H5O7.3K
C6H7K3O8
C6H8O7
CCRIS 6543
CCRIS 6566
CHEBI:64733
CHEBI:64746
CHEMBL1200458
Citric acid tripotassium salt
citric acid tripotassium salt (anh.)
citric acid tripotassium salt (anhydrous)
Citric acid, potassium salt
Citric acid, tripotassium salt
Citric acid, tripotassium salt, monohydrate
CTK3E8103
CTK3J3266
D05578
D07QPM
DB09125
DR001267
DTXSID8027325
DTXSID8042501
E332
EC 212-755-5
EE90ONI6FF
EINECS 212-755-5
EINECS 231-905-0
FT-0653076
HSDB 1248
I14-7714
K citrate
K544
Kajos
Kalii citras
Kaliksir
KSC448C0H
KSC493E6N
Litocit
LS-177940
LS-2418
MFCD00150442
MolPort-028-746-014
OR067644
OR340561
OR353803
PJAHUDTUZRZBKM-UHFFFAOYSA-K
Polycitra K
Porekal
POTASSIUM 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE HYDRATE (3:1:1)
Potassium citrate
potassium citrate (anh.)
Potassium Citrate (anhydrous)
Potassium citrate (USP)
Potassium Citrate [USAN]
Potassium citrate [USP]
Potassium citrate anhydrous
Potassium citrate monohydrate
Potassium citrate tribasic monohydrate
Potassium citrate tribasic monohydrate, >=98% (GC/titration)
Potassium citrate tribasic monohydrate, cell culture tested
Potassium citrate tribasic monohydrate, meets analytical specification of Ph. Eur., BP, FCC, E332, 99-100.5% (calc with ref. to anhyd. subst.)
Potassium citrate tribasic monohydrate, meets USP testing specifications
Potassium citrate tribasic monohydrate, puriss., 99.5%
Potassium citrate tribasic monohydrate, purum p.a., >=99.0% (NT)
Potassium citrate tribasic monohydrate, SAJ special grade, >=99.0%
Potassium citrate tribasic monohydrate, tested according to Ph.Eur.
Potassium citrate tribasic monohydrate, Vetec(TM) reagent grade, 98%
Potassium citrate tribasic solution
Potassium citrate tribasic solution, 1M in water 100ml
Potassium citrate tribasic solution, BioUltra, 1 M in H2O
Potassium citrate, United States Pharmacopeia (USP) Reference Standard
potassium citrate.H2O
Potassium tribasic citrate
Potassiumcitrate
Potassiumcitratemonohydrate
Q781
QEEAPRPFLLJWCF-UHFFFAOYSA-K
RL05371
RTR-021016
RTR-024823
Seltz-K
TR-021016
TR-024823
TRA0011227
tri potassium citrate
tri-potassium citrate monohydrate
Tripotassium 2-hydroxy-1,2,3-propanetricarboxylate monohydrate
tripotassium 2-hydroxypropane-1,2,3-tricarboxylate
Tripotassium 2-hydroxypropane-1,2,3-tricarboxylate Hydrate
tripotassium 2-hydroxypropane-1,2,3-tricarboxylate--water (1/1)
tripotassium 2-oxidanylpropane-1,2,3-tricarboxylate
TRIPOTASSIUM CITRATE
tripotassium citrate (anh.)
tripotassium citrate (anhydrous)
tripotassium citrate anhydrous
Tripotassium citrate monohydrate
Twin-K
UNII-86R1NVR0HW
UNII-EE90ONI6FF
Urocit K
Urocit-K (TN)
X3586

US Patents and Regulatory Information for UROCIT-K

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mission Pharma UROCIT-K potassium citrate TABLET, EXTENDED RELEASE;ORAL 019071-001 Aug 30, 1985 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mission Pharma UROCIT-K potassium citrate TABLET, EXTENDED RELEASE;ORAL 019071-002 Aug 31, 1992 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mission Pharma UROCIT-K potassium citrate TABLET, EXTENDED RELEASE;ORAL 019071-003 Dec 30, 2009 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Daiichi Sankyo
US Department of Justice
McKesson
Cantor Fitzgerald
McKinsey
Moodys
Baxter
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.